Correction: Is no test better than a bad test: Impact of diagnostic uncertainty on the spread of COVID-19.

[This corrects the article DOI: 10.1371/journal.pone.

Is "no test is better than a bad test"? Impact of diagnostic uncertainty in mass testing on the spread of COVID-19.

Testing is viewed as a critical aspect of any strategy to tackle epidemics. Much of the dialogue around testing has concentrated on how countries can scale up capacity, but the uncertainty in testing has not received nearly as much attention beyond asking if a test is accurate enough to be used. Even for highly accurate tests, false positives and false negatives will accumulate as mass testing strategies are employed under pressure, and these misdiagnoses could have major implications on the ability of governments to suppress the virus.

Anti-VEGF intervention in neovascular AMD: benefits and risks restated as natural frequencies.

Objective: Clear information is essential to properly determine preference in medical intervention. In neovascular age-related macular degeneration, patients need to understand the balance of risk and benefit of anti-vascular endothelial growth factor (VEGF) treatment. This balance is altered by the number of injections administered.